BackDeep Medicine Acquisition - Tradeable Rights - Oct 2026 Overview

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Current Assets

Deep Medicine Acquisition - Tradeable Rights - Oct 2026's current assets is $14M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$14.38M
21.16% YoYΔ $-3.86M vs prior year quarter

Peer average

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Current Assets History

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 vs. peers: Current Assets Comparison

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) FAQ

The latest current assets for DMAQR is $14M as of March 2026. That compares with $18M in the prior-year period — down 21.2% year over year. Investors often review this figure alongside Deep Medicine Acquisition - Tradeable Rights - Oct 2026's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQR's current assets moved from $18M to $14M — a 21.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Tradeable Rights - Oct 2026's operating scale or balance-sheet position.

A current assets figure of $14M for DMAQR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAQR's current assets ($14M), review year-over-year change from $18M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.